Abeona Therapeutics: ZEVASKYN Data Key In Gauging Momentum - Why I Hold (NASDAQ:ABEO)

Core Insights - Abeona Therapeutics Inc. (ABEO) stock has experienced a significant decline, falling by double-digit percentages this year, and is currently trading near its 52-week lows, which may present attractive entry points for investors [1] Company Overview - Abeona Therapeutics is facing challenges in its stock performance, with a notable drop in value that could indicate potential investment opportunities for those looking to enter at lower price points [1]